Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
CBER Director Vinay Prasad dared to “say no to drugs”
Podcast

CBER Director Vinay Prasad dared to “say no to drugs”

March 18, 2026
One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
Podcast

One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome

March 11, 2026
Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
Podcast

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

March 04, 2026
The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
PodcastThe Directors

The Directors: Yolanda Sanchez and Kelvin Lee talk about making cancer centers more resilient
“Diverse ecosystems are more robust than non-diverse ecosystems. That is a biological fact.”

February 27, 2026
Vol.52 No.08
By Claire Marie Porter and Paul Goldberg
Joni Nelson tells us how her background led her to pursue research that meets the needs of the community
Black History MonthPodcast

Joni Nelson tells us how her background led her to pursue research that meets the needs of the community
“I’m standing on the shoulders of giants”

February 27, 2026
Vol.52 No.08
By Joni D. Nelson, Robert A. Winn and Preston Willett
Fires, F-bombs, and facemasks—Study results show impact of LA fires on firefighter cancer risk
Podcast

Fires, F-bombs, and facemasks—Study results show impact of LA fires on firefighter cancer risk

February 25, 2026
Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
Black History MonthPodcast

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

February 20, 2026
Vol.52 No.07
By Malcolm V. Brock, Robert A. Winn and Preston Willett
Lowy fields questions about peer review at inaugural meeting of the new NCAB ad hoc working group
Podcast

Lowy fields questions about peer review at inaugural meeting of the new NCAB ad hoc working group

February 18, 2026
One year of The Cancer Letter Podcast: “When you publish a story, there is, you hope, conversation.”
Podcast

One year of The Cancer Letter Podcast: “When you publish a story, there is, you hope, conversation.”

February 11, 2026
Black History Month: Otis Brawley shares how lessons learned in West Side Detroit shape his stance on cancer prevention
Black History MonthPodcast

Black History Month: Otis Brawley shares how lessons learned in West Side Detroit shape his stance on cancer prevention
“Trying to realize how good we actually could be if our system were truly efficient is what Otis is all about”

February 06, 2026
Vol.52 No.05
By Robert A. Winn, Otis W. Brawley and Preston Willett

Posts navigation

123…8Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account